• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 10604
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Death (1802); Respiratory Distress (2045); Tachycardia (2095); Heart Failure (2206); Stenosis (2263)
Event Date 01/01/2019
Event Type  Death  
Manufacturer Narrative
Device is combination product.
 
Event Description
(b)(6) study.It was reported that arterial hypotension, in-stent restenosis and cardiac arrest which led to death occurred.On (b)(6) 2017, the patient was referred for elective cardiac catheterization.The target lesion was 95% stenosed, 20 mm long with a reference vessel diameter of 2.5 mm located in the first obtuse marginal artery (om1).The target lesion was treated with direct placement of a 2.50 x 24 mm study stent with 0% residual stenosis.The patient was discharged on dual antiplatelet therapy (aspirin and clopidogrel).On (b)(6) 2018, the patient experienced chest pain due to chronic polymyalgia rheumatica and pulmonary embolism.On (b)(6) 2018, the patient was hospitalized due to arterial hypotension and was treated with medication.On the same day, the patient was also diagnosed with in-stent restenosis in the first obtuse marginal artery (om1) and had "an" elevated troponin levels but did not meet criteria of myocardial infarction (mi).Eight days later, the patient was treated with medications in response to om1 in-stent restenosis and elevated troponin level.The patient was not a good candidate for coronary artery bypass grafting (cabg) surgery and percutaneous coronary intervention (pci) was particularly not feasible to any coronary artery.Additionally, the in-stent restenosis was only a diagnosis.The patient was discharged two days later from the hospital on aspirin and clopidogrel.On (b)(6) 2019, the patient presented in emergency department for the evaluation of dyspnea.An ekg revealed sinus tachycardia with premature ventricular complexes.The patients family stated that the patient had been suffering from shortness of breath for several days but condition had worsened over the last 24 hours.On physical examination, the patient was noted to be in severe respiratory distress and in tachycardia state.In emergency "the" department, the patient was diagnosed with cardiac arrest and acute on chronic systolic (congestive heart failure).The patient was treated with medication in response to the events.The patient and the family did not want any aggressive treatment further and hence, the patient was on a do not resuscitate (dnr) as per the patient and "families" request.The patient then expired.The cause of death was acute on chronic systolic heart failure and cardiac arrest.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
sonali arangil
two scimed place
maple grove, MN 55311
6515827403
MDR Report Key8286295
MDR Text Key134382486
Report Number2134265-2019-00347
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840213
UDI-Public08714729840213
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/29/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/14/2018
Device Model Number10604
Device Catalogue Number10604
Device Lot Number0020447537
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/03/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/14/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age78 YR
-
-